LV10294A - Kimiskas vielas (biologiski noardamie polimeri) - Google Patents

Kimiskas vielas (biologiski noardamie polimeri)

Info

Publication number
LV10294A
LV10294A LV930170A LV930170A LV10294A LV 10294 A LV10294 A LV 10294A LV 930170 A LV930170 A LV 930170A LV 930170 A LV930170 A LV 930170A LV 10294 A LV10294 A LV 10294A
Authority
LV
Latvia
Prior art keywords
pct
sec
carbon
organic group
date
Prior art date
Application number
LV930170A
Other languages
English (en)
Other versions
LV10294B (en
Inventor
Jo Klaveness
Keith Redford
Jan Solberg
Per Strande
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of LV10294A publication Critical patent/LV10294A/lv
Publication of LV10294B publication Critical patent/LV10294B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
LVP-93-170A 1992-03-06 1993-03-05 Chemical compounds (biodegradable polymers) LV10294B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204918A GB9204918D0 (en) 1992-03-06 1992-03-06 Chemical compounds

Publications (2)

Publication Number Publication Date
LV10294A true LV10294A (lv) 1994-10-20
LV10294B LV10294B (en) 1995-12-20

Family

ID=10711636

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-170A LV10294B (en) 1992-03-06 1993-03-05 Chemical compounds (biodegradable polymers)

Country Status (30)

Country Link
US (1) US5574097A (lv)
EP (1) EP0629214B1 (lv)
JP (1) JP3281381B2 (lv)
CN (1) CN1038940C (lv)
AT (1) ATE144540T1 (lv)
AU (1) AU670069B2 (lv)
BG (1) BG99070A (lv)
BR (1) BR9306043A (lv)
CA (1) CA2130671A1 (lv)
CZ (1) CZ281738B6 (lv)
DE (1) DE69305628T2 (lv)
DK (1) DK0629214T3 (lv)
ES (1) ES2093413T3 (lv)
FI (1) FI944078A7 (lv)
GB (1) GB9204918D0 (lv)
GR (1) GR3022075T3 (lv)
HU (1) HUT69070A (lv)
IL (1) IL104962A (lv)
LT (2) LT3216B (lv)
LV (1) LV10294B (lv)
MD (2) MD940199A (lv)
NO (1) NO303123B1 (lv)
NZ (1) NZ249547A (lv)
OA (1) OA10097A (lv)
PH (1) PH30746A (lv)
PL (1) PL174125B1 (lv)
RU (1) RU2114865C1 (lv)
SK (1) SK105694A3 (lv)
WO (1) WO1993018070A1 (lv)
ZA (2) ZA931599B (lv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
GB9318288D0 (en) * 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
CA2164237A1 (en) * 1994-12-08 1996-06-09 Takeharu Tabuchi Acrylic monomer
TW503116B (en) * 1997-12-12 2002-09-21 Kimberly Clark Co Structure having balanced pH profile
US6309999B1 (en) * 1999-03-19 2001-10-30 Chandra P. Sharma Process for the preparation of an immunoadsorbent matrix
RU2175338C2 (ru) * 1999-05-05 2001-10-27 Дугуев Сергей Владимирович Способ получения органоминеральных пигментов
US6720445B2 (en) 2000-12-21 2004-04-13 Beacon Laboratories, Inc. Acetyloxymethyl esters and methods for using the same
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ATE540678T1 (de) 2001-06-11 2012-01-15 Xenoport Inc Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
EP2075014B9 (en) 2002-05-24 2012-02-01 Angiotech International Ag Compositions and methods for coating medical implants
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
CA2536192A1 (en) * 2003-11-20 2005-06-09 Angiotech International Ag Soft tissue implants and anti-scarring agents
CA2584338C (en) 2004-11-04 2013-08-06 Xenoport, Inc. Gabapentin prodrug sustained release oral dosage forms
AU2005100176A4 (en) * 2005-03-01 2005-04-07 Gym Tv Pty Ltd Garbage bin clip
JP2011505179A (ja) 2007-11-23 2011-02-24 テヒニーシェ ウニヴェルジテート ウィーン ポリビニルアルコールベースの生分解性、生体適合性、架橋ポリマーの調製用重合硬化性組成物
ES2485899T3 (es) * 2010-06-17 2014-08-14 Basf Se Polímeros con grupos laterales sacárido y su uso
RU2543895C2 (ru) * 2013-05-17 2015-03-10 Общество С Ограниченной Ответственностью "Научно-Производственный Центр "Амфион" Гидрогелевый материал на основе сшиваемого поливинилового спирта
JP7115914B2 (ja) 2017-06-23 2022-08-09 住友化学株式会社 レジスト組成物及びレジストパターンの製造方法
GB201810788D0 (en) * 2018-06-29 2018-08-15 Biocompatibles Uk Ltd Biodegradable polymer
RU2687231C1 (ru) * 2018-08-03 2019-05-08 Сергей Борисович Врублевский Способ получения пигментов
CN109928879A (zh) * 2019-03-05 2019-06-25 贵州大学 一种丙烯酸酯碳酸酯及其均聚物和共聚物材料
CN111892707B (zh) * 2020-06-18 2021-08-13 中山大学 一种阳离子聚酰胺材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
DE3463211D1 (en) 1983-07-01 1987-05-21 Battelle Memorial Institute Biodegradable polypeptide and its use in the sustained release of medicaments
US4741956A (en) * 1986-07-09 1988-05-03 Exxon Research And Engineering Company Biodegradable coatings of ionomer polymer
DE58908194D1 (de) 1988-02-05 1994-09-22 Schering Ag Ultraschallkontrastmittel, verfahren zu deren herstellung und deren verwendung als diagnostika und therapeutika.
GB9003821D0 (en) 1990-02-20 1990-04-18 Danbiosyst Uk Diagnostic aid
US5137928A (en) 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
PH31064A (en) 1990-09-07 1998-02-05 Nycomed As Of Nycoveten Polymers containing diester units.

Also Published As

Publication number Publication date
AU670069B2 (en) 1996-07-04
GB9204918D0 (en) 1992-04-22
BG99070A (bg) 1995-08-28
LTIP391A (en) 1994-09-25
CZ281738B6 (cs) 1997-01-15
DK0629214T3 (da) 1996-11-18
OA10097A (en) 1996-12-18
CN1038940C (zh) 1998-07-01
GR3022075T3 (en) 1997-03-31
NO943273L (no) 1994-09-05
AU3642393A (en) 1993-10-05
ZA931594B (en) 1993-09-27
JPH07505177A (ja) 1995-06-08
JP3281381B2 (ja) 2002-05-13
RU94045151A (ru) 1996-09-27
EP0629214B1 (en) 1996-10-23
HU9402563D0 (en) 1994-11-28
BR9306043A (pt) 1997-11-18
RU2114865C1 (ru) 1998-07-10
PL174125B1 (pl) 1998-06-30
WO1993018070A1 (en) 1993-09-16
IL104962A (en) 1996-01-31
SK105694A3 (en) 1995-04-12
LT3216B (en) 1995-04-25
PH30746A (en) 1997-10-17
DE69305628D1 (de) 1996-11-28
ES2093413T3 (es) 1996-12-16
EP0629214A1 (en) 1994-12-21
ZA931599B (en) 1993-12-28
MD940199A (ro) 1996-01-31
FI944078A0 (fi) 1994-09-05
US5574097A (en) 1996-11-12
LT3199B (en) 1995-03-27
NO303123B1 (no) 1998-06-02
LTIP388A (en) 1994-09-25
DE69305628T2 (de) 1997-03-06
MD940206A (ro) 1996-01-31
FI944078L (fi) 1994-09-05
NO943273D0 (no) 1994-09-05
LV10294B (en) 1995-12-20
FI944078A7 (fi) 1994-09-05
CA2130671A1 (en) 1993-09-07
HUT69070A (en) 1995-08-28
CN1084524A (zh) 1994-03-30
ATE144540T1 (de) 1996-11-15
CZ215294A3 (en) 1995-08-16
IL104962A0 (en) 1993-07-08
NZ249547A (en) 1996-08-27

Similar Documents

Publication Publication Date Title
LV10294A (lv) Kimiskas vielas (biologiski noardamie polimeri)
Nielsen et al. Synthesis and characterization of dinucleoside phosphorodithioates
NO304432B1 (no) Biodegraderbare polymerer, fremstilling og anvendelse av slike
BG100467A (bg) Повърхностноактивен полимер с капсулирани микромехурчета и тяхното използване в ултразвуково изображение
GR1003202B (el) Νεα παρασιτοκτονα.
DE69326447D1 (de) Verbesserungen in bezug auf kontrastmittel
TR199900848T2 (xx) Oksadiazoller, elde edilmeleri ve ila� olarak kullan�mlar�.
DE69933665D1 (de) Nicht-elastomere polyurethanzusammensetzungen
ATE249466T1 (de) Silizium enthaltender kettenverlängerer
ATE438096T1 (de) Hla-e bindung zu cd94/nkg2+ zellen
DE69306757D1 (de) Landwirtschaftliche verbesserungen
IT1231157B (it) Nuovi geni ibridi funzionali di bacillus thuringiensis ottenuti mediante ricombinazione in vivo.
TW363072B (en) Copolymers based on vinyl units and their use in electroluminescent devices
ES2092116T3 (es) Policarbonatos y sus usos para la preparacion de matrices bioerosionables.
NO175313C (no) Joderte polymerer og deres anvendelse
TR200001745T2 (tr) Keton peroksit türevleri, bunların hazırlanması ve kullanılması
ES2105425T3 (es) Composiciones, formadas por polimeros electroconductores y poliuretanos.
FI963055A0 (fi) Kondensaatio- ja additiopolymeereja, jotka sisältävät N,N'-sillan sisältäviä bis(tetrametyylipiperidinyylioksi)-ryhmiä
BR9809767A (pt) Sulfoniloxadiazolonas
KR950700348A (ko) 중합체 배합물과 상용화제(polymer blends and compatibilisers)